BlackRock Inc. - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 280 filers reported holding CONMED CORP in Q2 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$499,112,502
-26.0%
4,949,058
-0.3%
0.01%
-26.3%
Q2 2023$674,852,444
+32.1%
4,966,167
+1.0%
0.02%
+26.7%
Q1 2023$510,881,012
+17.1%
4,918,939
-0.1%
0.02%
+7.1%
Q4 2022$436,371,885
+13.2%
4,922,968
+2.4%
0.01%
+7.7%
Q3 2022$385,342,000
-13.1%
4,806,572
+3.8%
0.01%
-7.1%
Q2 2022$443,356,000
-36.1%
4,629,871
-0.9%
0.01%
-26.3%
Q1 2022$693,842,000
+5.8%
4,670,760
+0.9%
0.02%
+11.8%
Q4 2021$656,083,000
+12.2%
4,628,128
+3.5%
0.02%
+6.2%
Q3 2021$584,908,000
-7.3%
4,470,754
-2.6%
0.02%
-11.1%
Q2 2021$630,798,000
+2.5%
4,589,949
-2.6%
0.02%0.0%
Q1 2021$615,228,000
+22.7%
4,711,125
+5.2%
0.02%
+12.5%
Q4 2020$501,515,000
+49.6%
4,477,801
+5.1%
0.02%
+33.3%
Q3 2020$335,226,000
+7.0%
4,261,172
-2.1%
0.01%
-7.7%
Q2 2020$313,282,000
+29.7%
4,351,722
+3.2%
0.01%
+8.3%
Q1 2020$241,501,000
-50.3%
4,216,870
-3.0%
0.01%
-36.8%
Q4 2019$486,333,000
+18.2%
4,348,855
+1.6%
0.02%
+11.8%
Q3 2019$411,526,000
+17.6%
4,280,061
+4.7%
0.02%
+13.3%
Q2 2019$349,823,000
+0.5%
4,088,147
-2.3%
0.02%
-6.2%
Q1 2019$348,227,000
+27.0%
4,186,441
-2.0%
0.02%
+14.3%
Q4 2018$274,240,000
-14.2%
4,271,666
+5.9%
0.01%0.0%
Q3 2018$319,555,000
+16.1%
4,033,768
+7.3%
0.01%
+7.7%
Q2 2018$275,184,000
+22.1%
3,759,374
+5.6%
0.01%
+18.2%
Q1 2018$225,348,000
+34.7%
3,558,330
+8.4%
0.01%
+37.5%
Q4 2017$167,275,000
-0.3%
3,281,817
+2.7%
0.01%0.0%
Q3 2017$167,737,000
+5.6%
3,196,795
+2.5%
0.01%0.0%
Q2 2017$158,800,000
+13.4%
3,117,406
-1.1%
0.01%0.0%
Q1 2017$140,043,000
+46271.9%
3,153,427
+46036.5%
0.01%
Q4 2016$302,000
-83.0%
6,835
-84.6%
0.00%
-100.0%
Q3 2016$1,779,000
-15.6%
44,397
+0.5%
0.00%0.0%
Q2 2016$2,107,000
+29.3%
44,158
+13.7%
0.00%0.0%
Q1 2016$1,629,000
-2.2%
38,846
+2.7%
0.00%
+50.0%
Q4 2015$1,666,000
-20.2%
37,811
-13.6%
0.00%
-33.3%
Q3 2015$2,089,000
+71.8%
43,769
+109.6%
0.00%
+50.0%
Q2 2015$1,216,000
+3186.5%
20,884
+2784.5%
0.00%
Q1 2015$37,000
-51.3%
724
-57.5%
0.00%
Q4 2014$76,000
+22.6%
1,7030.0%0.00%
Q3 2014$62,000
-69.5%
1,703
-62.9%
0.00%
Q2 2014$203,000
+395.1%
4,592
+380.3%
0.00%
Q1 2014$41,0000.0%9560.0%0.00%
Q4 2013$41,000
+20.6%
956
-4.5%
0.00%
Q3 2013$34,000
+9.7%
1,0010.0%0.00%
Q2 2013$31,0001,0010.00%
Other shareholders
CONMED CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 217,204$29,850,0003.08%
Ranger Investment Management 260,524$35,804,0001.87%
EARNEST PARTNERS LLC 1,628,848$223,853,0001.32%
Penn Capital Management Company, LLC 87,232$11,988,0001.16%
DeepCurrents Investment Group LLC 257,334$35,365,0001.06%
Champlain Investment Partners, LLC 1,475,989$202,845,0000.96%
Hood River Capital Management LLC 224,050$30,791,0000.92%
OAK RIDGE INVESTMENTS LLC 74,178$10,194,0000.89%
MOODY ALDRICH PARTNERS LLC 45,667$6,276,0000.88%
WAFRA INC. 138,542$19,040,0000.72%
View complete list of CONMED CORP shareholders